⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

Official Title: A Phase 1/2 Open-Label Multicenter Trial to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

Study ID: NCT05668585

Study Description

Brief Summary: The purpose of this study is to evaluate the safety and tolerability of CFT1946 as well as to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CFT1946 as monotherapy (Arm A) and in combination with trametinib (CFT1946 + trametinib; Arm B) or Cetuximab (CFT1946 + cetuximab; Arm C).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Florida Cancer Specialists, Sarasota, Florida, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Washington University School of Medicine, Saint Louis, Missouri, United States

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States

Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States

MD Anderson Cancer Center, Houston, Texas, United States

Virginia Cancer Specialists (NEXT Oncology Virginia), Fairfax, Virginia, United States

University of Wisconsin, Madison, Wisconsin, United States

Institut Bergonie, Bordeaux Cedex, , France

Chu de Lille, Lille, , France

Centre Leon Berard, Lyon, , France

IUCT Oncopole, Toulouse, , France

NEXT Oncology Barcelona, Barcelona, , Spain

Hospital Universitario Vall d'Hebron, Barcelona, , Spain

South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jiminez Diaz, Madrid, , Spain

Hospital Clinico Universitario de Valencia, Valencia, , Spain

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: